- Home
- ASTI vs BIAF Comparison
ASTI vs BIAF Comparison
Compare ASTI & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- BIAF
- Stock Information
- Founded
- ASTI 2005
- BIAF 2014
- Country
- ASTI United States
- BIAF United States
- Employees
- ASTI N/A
- BIAF N/A
- Industry
- ASTI Semiconductors
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ASTI Technology
- BIAF Health Care
- Exchange
- ASTI Nasdaq
- BIAF Nasdaq
- Market Cap
- ASTI 6.7M
- BIAF 7.6M
- IPO Year
- ASTI N/A
- BIAF 2022
- Fundamental
- Price
- ASTI $2.13
- BIAF $3.01
- Analyst Decision
- ASTI
- BIAF Hold
- Analyst Count
- ASTI 0
- BIAF 1
- Target Price
- ASTI N/A
- BIAF N/A
- AVG Volume (30 Days)
- ASTI 235.3K
- BIAF 8.3M
- Earning Date
- ASTI 11-13-2025
- BIAF 11-13-2025
- Dividend Yield
- ASTI N/A
- BIAF N/A
- EPS Growth
- ASTI N/A
- BIAF N/A
- EPS
- ASTI N/A
- BIAF N/A
- Revenue
- ASTI $41,135.00
- BIAF $7,681,059.00
- Revenue This Year
- ASTI N/A
- BIAF N/A
- Revenue Next Year
- ASTI N/A
- BIAF $20.04
- P/E Ratio
- ASTI N/A
- BIAF N/A
- Revenue Growth
- ASTI N/A
- BIAF 4.99
- 52 Week Low
- ASTI $1.10
- BIAF $2.34
- 52 Week High
- ASTI $4.41
- BIAF $67.12
- Technical
- Relative Strength Index (RSI)
- ASTI 48.30
- BIAF 50.89
- Support Level
- ASTI $2.08
- BIAF $2.55
- Resistance Level
- ASTI $2.53
- BIAF $3.50
- Average True Range (ATR)
- ASTI 0.20
- BIAF 0.34
- MACD
- ASTI -0.00
- BIAF -0.11
- Stochastic Oscillator
- ASTI 36.31
- BIAF 52.71
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.